Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Candidemia D058387 2 associated lipids
Aspergillosis D001228 5 associated lipids
Blastomycosis D001759 5 associated lipids
Xerostomia D014987 6 associated lipids
Vaginitis D014627 6 associated lipids
Gonorrhea D006069 7 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Otitis Externa D010032 8 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Urethritis D014526 9 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
Influenza, Human D007251 11 associated lipids
Candidiasis, Oral D002180 11 associated lipids
HIV Seropositivity D006679 15 associated lipids
Dermatomycoses D003881 17 associated lipids
Mycoses D009181 18 associated lipids
Leishmaniasis D007896 19 associated lipids
Burns D002056 34 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Peritonitis D010538 38 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Hemolysis D006461 131 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Hellinger WC et al. A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation. 2002 Transplantation pmid:12131685
Lopez-De-Blanc SA et al. Antifungal topical therapy in oral chronic candidosis. A comparative study. 2002 Jul-Oct Med Oral pmid:12134127
Giaever G et al. Functional profiling of the Saccharomyces cerevisiae genome. 2002 Nature pmid:12140549
Iwabuchi K and Nagaoka I Lactosylceramide-enriched glycosphingolipid signaling domain mediates superoxide generation from human neutrophils. 2002 Blood pmid:12149231
Bauters TG et al. Colonization of voice prostheses by albicans and non-albicans Candida species. 2002 Laryngoscope pmid:12152601
Stuart AD et al. A novel cell entry pathway for a DAF-using human enterovirus is dependent on lipid rafts. 2002 J. Virol. pmid:12186914
Selinka HC et al. Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions. 2002 Virology pmid:12202231
Anil S and Samaranayake LP Impact of lysozyme and lactoferrin on oral Candida isolates exposed to polyene antimycotics and fluconazole. 2002 Oral Dis pmid:12206401
Marrazzo J Vulvovaginal candidiasis. 2002 BMJ pmid:12228137
Volpon L and Lancelin JM Solution NMR structure of five representative glycosylated polyene macrolide antibiotics with a sterol-dependent antifungal activity. 2002 Eur. J. Biochem. pmid:12230565